Obinutuzumab (GA101) is highly effective against chronic lymphocytic leukemia cells in ex vivo B-cell depletion irrespective of high-risk prognostic markers

Detalles Bibliográficos
Autores principales: Ysebaert, L, Laprévotte, E, Klein, C, Quillet-Mary, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670946/
https://www.ncbi.nlm.nih.gov/pubmed/26565404
http://dx.doi.org/10.1038/bcj.2015.93

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670946/
https://www.ncbi.nlm.nih.gov/pubmed/26565404
http://dx.doi.org/10.1038/bcj.2015.93

Ejemplares similares